The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, investigators from the CBTCT will review major topics in stem cell transplantation and cell therapy, highlighting how the activities of the CBTCT are addressing current challenges in stem cell transplantation. The fifth webinar in this series features two excellent speakers, with Dr Kate Markey highlighting the emerging significance of the microbiome in influencing outcomes following blood and marrow transplantation, followed by Elissa Atkins who will review the practical aspects of the regulatory requirements for the monitoring of recipients of immune effector cell therapy products.

Speakers:

Dr Kate Markey – Memorial Sloan Kettering Cancer Centre / Weill Cornell Medical College

Elissa Atkins – Westmead Hospital / Westmead Institute for Medical Research

When: Thursday 1 October 2020, 8am AEST

Link to webinar:

Link to CBTCT website for all webinar recordings:

PDF flyer